Patents by Inventor Nathalie GÉRARD

Nathalie GÉRARD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and composition for an anion tolerant lubricant
    Patent number: 10662393
    Abstract: The presently disclosed subject matter Is directed to formulations for lubricating a conveyor belt used in beverage packaging. One of the disclosed lubricant compositions comprises water, at least one amphoteric surfactant, at least one anionic surfactant and at least one non-ionic surfactant. Also disclosed is a system for applying a lubricant to a conveyor belt and a method for lubricating a conveyor belt.
    Type: Grant
    Filed: May 4, 2016
    Date of Patent: May 26, 2020
    Assignee: Diversey, Inc.
    Inventors: Nathalie Gérard, Stefan Grober, Markus Wloka, Henry Von Rège, Chivukula V. S. N. Murthy, Hemant Godbole
  • METHOD AND COMPOSITION FOR AN ANION TOLERANT LUBRICANT
    Publication number: 20180282657
    Abstract: The presently disclosed subject matter Is directed to formulations for lubricating a conveyor belt used in beverage packaging. One of the disclosed lubricant compositions comprises water, at least one amphoteric surfactant, at least one anionic surfactant and at least one non-ionic surfactant. Also disclosed is a system for applying a lubricant to a conveyor belt and a method for lubricating a conveyor belt.
    Type: Application
    Filed: May 4, 2016
    Publication date: October 4, 2018
    Inventors: Nathalie GÉRARD, Stefan GROBER, Markus WLOKA, Henry VON RÈGE, Chivukula V.S.N. MURTHY, Hemant GODBOLE
  • NOVEL ALTERNATIVE SPLICE TRANSCRIPTS FOR MHC CLASS I RELATED CHAIN ALPHA (MICA) AND USES THEREOF
    Publication number: 20160176943
    Abstract: The present invention relates to novel alternative splice transcripts (AST) for MICA (MHC class I related chain alpha) encoding novel MICA protein isoforms and uses thereof. In particular, the present invention relates to an isolated polypeptide at least 80% of identity with a sequence selected from the group consisting of SEQ ID NO:1 (MICA-A), SEQ ID NO:2 (MICA-B1), SEQ ID NO:3 (MICA-B2); SEQ ID NO:4 (MICA-C) and SEQ ID NO: (MICA-D).
    Type: Application
    Filed: July 4, 2014
    Publication date: June 23, 2016
    Applicant: INSERM (INSITITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Beatrice CHARREAU, Nathalie GERARD, Pierre TONNERRE, Pierre-Jean GAVLOVSKY